The impact of race on outcomes of autologous transplantation in patients with multiple myeloma
โ Scribed by Pramvir S. Verma; Robin S. Howard; Brendan M. Weiss
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 143 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Highโdose therapy and autologous stem cell transplant (HDT) have been shown to prolong survival in multiple myeloma (MM) in randomized trials, but only included patients of 65 years or younger. Given the median age at diagnosis of 66 years, it is important to have a better understanding
## Background: The effect of interleukin-6 (il-6), the major growth factor for myeloma cells, may be enhanced by soluble il-6 receptor (sil-6r). therefore, the current study investigated the clinical significance of serum sil-6r in patients with multiple myeloma (mm). ## Methods: Serum levels of